Clinical Trial Detail

NCT ID NCT04163900
Title Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer (NuTide:121)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors NuCana plc
Indications

ampulla of Vater adenocarcinoma

biliary tract cancer

Therapies

Cisplatin + NUC-1031

Cisplatin + Gemcitabine

Age Groups: senior adult

No variant requirements are available.